9 Results for "

IDH2-R172K

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "IDH2-R172K" in MCE Product Catalog:

17
17 Cited Publications
Cat. No.: HY-18690
CAS No.: 1446502-11-9
Synonyms: AG-221
Research Areas:  

Cancer

Enasidenib is an oral, potent, reversible, selective inhibitor of the IDH2 mutant enzymes, with IC50s of 100 and 400 nM against IDH2 R140Q and IDH2 R172K, respectively.
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-104042
CAS No.: 1644545-52-7
Purity:  99.87%
Synonyms: AG-881
Research Areas:  

Cancer

Vorasidenib (AG-881) is an orally available, brain penetrant second-generation dual mutant isocitrate dehydrogenases 1 and 2 (mIDH1/2) inhibitor. Vorasidenib (AG-881) exhibits nanomolar inhibition of (D)-2-hydroxyglutarate (D-2-HG), and the IC50 ranges of 0.04~22 nM against IDH1 R132C, IDH1 R132G, IDH1 R132H and IDH1 R132S and 7~14 nM against IDH2 R140Q and 130 nM against IDH2 R172K. Vorasidenib can be used for the study of grade 2 astrocytoma or oligodendroglioma with a susceptible IDH1/2 mutation .
loading...
    loading...
Cat. No.: HY-131312
CAS No.: 2230263-60-0
Synonyms: LY3410738; Mutant IDH1-IN-6
Research Areas:  

Cancer

Mutant IDH1-IN-6 is a potent, selective and orally active mutant isocitrate dehydrogenase (IDH) inhibitor with IC50s of 6.27 nM, 3.71 nM, 36.9 nM and 11.5 nM for IDH1 R132H, IDH1 R132C, IDH2 R140Q and IDH2 R172K mutant enzymes, respectively. Mutant IDH1-IN-6 is less active at inhibiting the IDH wild-type enzymes .
loading...
    loading...
Cat. No.: HY-18690R
CAS No.: 1446502-11-9
Synonyms: AG-221 (Standard)
Enasidenib (Standard) is the analytical standard of Enasidenib. This product is intended for research and analytical applications. Enasidenib is an oral, potent, reversible, selective inhibitor of the IDH2 mutant enzymes, with IC50s of 100 and 400 nM against IDH2R140Q and IDH2R172K, respectively.
loading...
    loading...
Cat. No.: HY-164542
CAS No.: 2071196-10-4
Research Areas:  

Cancer

TQ05310 is an orally available inhibitor of IDH2 mutants, targeting both IDH2-R140Q (IC50=136.9 nM) and IDH2-R172K (IC50=37.9 nM) mutants. TQ05310 inhibits the production of 2-hydroxyglutarate (2-HG) and induces differentiation of cells expressing IDH2-R140Q and IDH2-R172K by inhibiting the enzymatic activity of mutant IDH2. TQ05310 can be used for the study of acute myeloid leukemia .
loading...
    loading...
Cat. No.: HY-131312A
CAS No.: 2759438-85-0
Synonyms: LY3410738 gentisate; Mutant IDH1-IN-6 gentisate
Research Areas:  

Cancer

Crelosidenib (gentisate) is a potent, selective and orally active mutant isocitrate dehydrogenase (IDH) inhibitor with IC50 of 6.27 nM, 3.71 nM, 36.9 nM and 11.5 nM for IDH1 R132H, IDH1 R132C, IDH2 R140Q and IDH2 R172K mutant enzymes, respectively. Crelosidenib (gentisate) is less active at inhibiting the IDH wild-type enzymes .
loading...
    loading...
Cat. No.: HY-18690S
CAS No.: 2095569-76-7
Synonyms: AG-221-d6
Enasidenib-d6 (AG-221-d6) is the deuterium labeled Enasidenib (HY-18690) . Enasidenib is an oral, potent, reversible, selective inhibitor of the IDH2 mutant enzymes, with IC50s of 100 and 400 nM against IDH2 R140Q and IDH2 R172K, respectively .
loading...
    loading...
Cat. No.: HY-165546
CAS No.: 1643852-84-9
Target:  

Drug Metabolite

Research Areas:  

Others

AGI-16903 is a metabolite of Enasidenib (HY-18690). Enasidenib is an orally available, reversible, and selective inhibitor of mutant IDH2 enzymes, with IC50 values of 100 nM and 400 nM against IDH2 R140Q and IDH2 R172K, respectively .
loading...
    loading...
Cat. No.: HY-104042R
CAS No.: 1644545-52-7
Synonyms: AG-881 (Standard)
Vorasidenib (Standard) is the analytical standard of Vorasidenib (HY-104042). This product is intended for research and analytical applications. Vorasidenib (AG-881) is an orally available, brain penetrant second-generation dual mutant isocitrate dehydrogenases 1 and 2 (mIDH1/2) inhibitor. Vorasidenib (AG-881) exhibits nanomolar inhibition of (D)-2-hydroxyglutarate (D-2-HG), and the IC50 ranges of 0.04~22 nM against IDH1 R132C, IDH1 R132G, IDH1 R132H and IDH1 R132S and 7~14 nM against IDH2 R140Q and 130 nM against IDH2 R172K. Vorasidenib can be used for the study of grade 2 astrocytoma or oligodendroglioma with a susceptible IDH1/2 mutation .
loading...
    loading...